Business

Business Tara Bannow

STAT Plus: Banning surprise medical bills is raising costs elsewhere

The Readout Damian Garde

STAT Plus: Alnylam thickened the plot

The Readout Damian Garde

STAT Plus: Pharma’s contractors might finally be on the rebound

The Readout Meghana Keshavan

STAT Plus: Replicate’s srRNA rabies vaccine effective in Phase 1

Business Brittany Trang

STAT Plus: Private equity investment in Medicare Advantage drops

The Readout Meghana Keshavan

STAT Plus: The need to know biotech news stories today

The Readout Meghana Keshavan

STAT Plus: Psychedelic investment continues to ramp up

Business Brittany Trang

STAT Plus: States are ramping up scrutiny of health transactions, as more provider groups look for buyers

Business Bob Herman

STAT Plus: FTC doubles down in Welsh Carson anesthesia case to limit private equity’s physician buyouts

The Readout Meghana Keshavan

STAT Plus: Does Moderna’s RSV vaccine lose efficacy faster than others?

Business Tara Bannow

STAT Plus: Lasers, cardiology, clinical trials: 2023’s top private equity targets

The Readout Damian Garde

STAT Plus: Gilead sours on the ‘don’t eat me’ business

Business Casey Ross and Bob Herman

STAT Plus: Government warns Medicare Advantage insurers not to deny care based on AI

The Readout Damian Garde

STAT Plus: The GLP-1 panic is alive and well

The Readout Damian Garde

STAT Plus: Vertex still knows how to do what it does best

The Readout Meghana Keshavan

STAT Plus: Regeneron is interested in obesity treatments that combat muscle loss

Hospitals Tara Bannow

STAT Plus: New Medicare Advantage rule is boon for providers, drag on insurers

The Readout Meghana Keshavan

STAT Plus: What makes a drug a blockbuster — or a cautionary tale?

The Readout Damian Garde

Novavax is on thin ice, and the latest update isn’t exactly encouraging

The Readout Damian Garde

STAT Plus: Pfizer’s reset year starts with a little profit

The Readout Damian Garde

STAT Plus: How an immunological Trojan horse could treat disease

The Readout Meghana Keshavan

STAT Plus: 23andMe breach targeted Chinese, Jewish populations

The Readout Damian Garde

STAT Plus: Eli Lilly overtakes Tesla in market value

Business Thomas Lee — Boston Globe

STAT Plus: CVS wants to become a medical powerhouse. Will long lines and understaffing hold it back?

The Readout Damian Garde

STAT Plus: Another step toward new drugs for Parkinson’s

Business Rachel Cohrs

STAT Plus: A PBM in Africa flips the industry’s script in a bid to make people healthier

The Readout Meghana Keshavan

STAT Plus: Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment

Business Jessica Bartlett — Boston Globe

STAT Plus: A for-profit health system’s financial issues could plunge overburdened hospitals into crisis

The Readout Damian Garde

STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect